✦ LIBER ✦

Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation

✍ Scribed by Ono, A.; Kenmotsu, H.; Watanabe, M.; Serizawa, M.; Mori, K.; Imai, H.; Taira, T.; Naito, T.; Murakami, H.; Nakajima, T.; Ohde, Y.; Endo, M.; Yamamoto, N.; Koh, Y.; Takahashi, T.

Book ID: 126911331
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 218 KB
Volume: 25
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of EGFR Mutation Status in Lu

Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

✍ Brevet, Marie; Arcila, Maria; Ladanyi, Marc 📂 Article 📅 2010 🏛 American Society for Investigative Pathology 🌐 English ⚖ 781 KB

Denaturing capillary electrophoresis for

Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy

✍ Lucie Benesova; Milos Pesek; Barbora Belsanova; Patrik Sekerka; Marek Minarik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The presence of activating mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene has been attributed to a positive response to biological therapy of lung cancer by small‐molecular tyrosine kinase inhibitors, gefitinib and erlotinib. Among the two most

9017 POSTER DISCUSSION Initial Detection

9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib

✍ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB